Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax plus hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
Leukemia Research（2023）
关键词
Acute myeloid leukemia, AML, Outcomes, Gilteritinib, Ivosidenib, Enasidenib, Hypomethylating agents, HMA, Venetoclax, Targeted therapies
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要